Latest News for: P bcl

Edit

Phikwe Poised

The Voice Botswana 25 Jan 2022
Competition Authority approves partial BCL acquisition. The Competition and Consumer Authority (CCA) this week unconditionally approved the acquisition of certain assets belonging to BCL Limited by Premium Nickel Resources Botswana (PNRB) ... The relevant market to analyse therefore is that of the Target Enterprise, BCL,” she explained.
Edit

Buy BCL Industries, target price Rs 960: Equity99

The Times of India 24 Jan 2022
Equity99 has buy call on BCL Industries ... The current market price of BCL Industries is Rs 442.5 ... BCL Industries ...
Edit

ASH 2021 | Ascentage Pharma Presents Latest Data from Two Studies of Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a China Study Demonstrating Complete Responses

PR Newswire 14 Dec 2021
The company has built a pipeline of eight clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors (TKIs).
Edit

ASH 2021 | Ascentage Pharma Presents Latest Data from Two Studies of Bcl-2-Selective Inhibitor Lisaftoclax ...

Longview News-Journal 14 Dec 2021
The company has built a pipeline of eight clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors (TKIs).
Edit

Ascentage Pharma Announces CDE's Approval for the Phase II Pivotal Study in China of the Bcl-2 Inhibitor Lisaftoclax (APG-2575) for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

PR Newswire 13 Dec 2021
It is the first China-developed Bcl-2 inhibitor entering clinical development in China ... The company has built a pipeline of eight clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors (TKIs).
Edit

BCL Industries stock ends 5% higher after order win for supplies to OMCs

IIFL 06 Dec 2021
The Company also expects that its subsidiary viz. Svaksha Distillery Limited will also commence its commercial production of Ethanol in last quarter of this financial year 2021-22 ... .
Edit

Indonesia's DANAMON NEW LIVE! EXPERIENCE VOL.2 Goes Ahead Promising Excitement and New Experiences with BCL, NOAH and TULUS

PR Newswire 23 Nov 2021
JAKARTA, Indonesia, Nov ... Indonesia's DANAMON NEW LIVE! EXPERIENCE VOL.2 Goes Ahead Promising Excitement and New Experiences with BCL, NOAH and TULUS ... On the first day, the stunning BCL (Bunga Citra Lestari) appeared on stage and surprised the audience by inviting Ariel NOAH ... Danamon New Live! Experience Vol ... BCL (Bunga Citra Lestari), NOAH, TULUS ... .
Edit

Nornickel settles dispute with Botswana and BCL

Mining Weekly 18 Nov 2021
Russian mining company Norilsk Nickel (Nornickel) has settled its dispute with the ...
Edit

NORNICKEL SETTLES DISPUTE WITH BOTSWANA GOVERNMENT AND BCL (OJSC MMC Norilsk Nickel)

Public Technologies 18 Nov 2021
). London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content ... Disclaimer ... (noodl.
Edit

Global Bcl-2-Like Protein 1 Market 2021: Top Countries Analysis by Size, Share, Growth Insights, Trends, ...

MENA FN 16 Nov 2021
(MENAFN - America News Hour)In a recent published report, Kenneth Research has updated the Market report for Global Bcl-2-Like Protein 1 Market for 2021 till 2030. Report further now discusses; ... .
Edit

ASH 2021 | Ascentage Pharma to Release Latest Data from Two Studies of Its Bcl-2-Selective Inhibitor Lisaftoclax (APG-2575), Including a Chinese Study Demonstrating Complete Response

PR Newswire 05 Nov 2021
The company has built a pipeline of eight clinical drug candidates, including novel, highly potent Bcl-2, and dual Bcl-2/Bcl-xL inhibitors, as well as candidates aimed at IAP and MDM2-p53 pathways, and next-generation tyrosine kinase inhibitors (TKIs).
Edit

BMWU at Loggerheads With BCL Liquidator

The Botswana Gazette 04 Nov 2021
Sources say despite being members of BMWU, BCL employees are allegedly ...

Most Viewed

×